EC-18

· Enzychem Lifesciences Corporation

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for EC-18, covering 2016-01-11 to 2024-11-08. Get the full timeline:

Most recent: Clinical Trial Update: Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

See pricing